Pure Global

Sirolimus Eluting Coronary Stent System - India CDSCO Medical Device Registration

Sirolimus Eluting Coronary Stent System is a medical device registered with India's Central Drugs Standard Control Organization (CDSCO) under UID IMP/MD/2020/000134_dd9e936185c45bb38483da5470752fd4_8cc94b669a425bb039bfe840d47ae0bc. This device is marketed under the brand name Yukon Choice 4. The license holder is Translumina Therapeutics LLP, and it is classified as Device Class Class D. The approving authority is CDSCO.

This page provides comprehensive regulatory information including complete registration details, license holder information, device classification, and related products. Pure Global AI offers free access to 71,807+ India medical device registrations, helping global MedTech companies identify partners, analyze markets, and discover business opportunities efficiently.

Free Database
Powered by Pure Global AI
CDSCO Registered
Class Class D
Sirolimus Eluting Coronary Stent System
UID: IMP/MD/2020/000134_dd9e936185c45bb38483da5470752fd4_8cc94b669a425bb039bfe840d47ae0bc

Brand Name

Yukon Choice 4

Device Class

Class D

Approving Authority

CDSCO

Product Information

The Yukon Chrome PC Sirolimus Eluting Stent is indicated for improving luminal diameter and reducing restenosis for treatment of coronary artery lesions in native coronary arteries ranging from 2.0 mm to 4.0 mm. The Yukon Chrome PC Sirolimus Eluting Cobalt Chromium Coronary Stent System is indicated for intraluminal chronic placement in stenosed coronary artery or aorto-coronary bypass grafts in order to obtain vessel patency following acute or subacute coronary artery obstruction. It is also indicated for restenosis or arterial dissection after PTCA procedure. Patients being considered for stent implantation should be acceptable candidates for coronary balloon angioplasty.

Pure Global
DJ Fang

DJ Fang

MedTech Regulatory Expert

Need help with 30+ markets registration?

Pricing